Literature DB >> 1281193

Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.

C F Ware1, P D Crowe, M H Grayson, M J Androlewicz, J L Browning.   

Abstract

The expression of membrane-associated forms of lymphotoxin (LT) and TNF were examined on cell lines of T, B, and myeloid origin, IL-2 dependent T cell clones, and peripheral blood lymphocytes. Inducible and constitutive patterns of surface LT expression were found on T cells as exemplified by the II-23.D7, a CD4+T cell hybridoma, and HUT-78, a T cell lymphoma. Phorbol ester induced surface LT expression on Ramos, an EBV transformed B cell line, but at a slower rate of appearance when compared to the II-23.D7. Secretion of LT was rapidly inducible by phorbol ester in II-23.D7 and also in HUT-78 but with slower kinetics; surface LT expression continued in both lines after secretion had ceased. Low levels of membrane TNF were transiently induced on II-23.D7 and HUT-78, but none was observed on Ramos. Peripheral blood monocytes and some myeloid tumor lines did not express surface LT. Several T cell clones expressed surface LT after Ag-specific stimulation, and expression persisted several days. Stimulation through the TCR or by IL-2 rapidly induced surface LT on resting peripheral T cells and CD56+ NK cells; pokeweed mitogen activation induced expression on CD20+ B cells. Consistent with previous results, immunoprecipitation with anti-LT mAb showed that LT was complexed with a distinct 33 kDa glycoprotein (p33) on cells that expressed surface LT, whereas secreted LT was not associated with p33. Surface and secreted modes of LT expression by activated T, B, and NK cells suggests that LT can be utilized as either a localized or diffusible mediator in immune responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281193

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Signal regulatory protein α regulates the homeostasis of T lymphocytes in the spleen.

Authors:  Miho Sato-Hashimoto; Yasuyuki Saito; Hiroshi Ohnishi; Hiroko Iwamura; Yoshitake Kanazawa; Tetsuya Kaneko; Shinya Kusakari; Takenori Kotani; Munemasa Mori; Yoji Murata; Hideki Okazawa; Carl F Ware; Per-Arne Oldenborg; Yoshihisa Nojima; Takashi Matozaki
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

2.  Follicular dendritic cells emerge from ubiquitous perivascular precursors.

Authors:  Nike Julia Krautler; Veronika Kana; Jan Kranich; Yinghua Tian; Dushan Perera; Doreen Lemm; Petra Schwarz; Annika Armulik; Jeffrey L Browning; Michelle Tallquist; Thorsten Buch; José B Oliveira-Martins; Caihong Zhu; Mario Hermann; Ulrich Wagner; Robert Brink; Mathias Heikenwalder; Adriano Aguzzi
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

3.  Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.

Authors:  M B Alimzhanov; D V Kuprash; M H Kosco-Vilbois; A Luz; R L Turetskaya; A Tarakhovsky; K Rajewsky; S A Nedospasov; K Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.

Authors:  Raja K Sivamani; Heidi Goodarzi; Miki Shirakawa Garcia; Siba P Raychaudhuri; Lisa N Wehrli; Yoko Ono; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 5.  LIGHT-related molecular network in the regulation of innate and adaptive immunity.

Authors:  Yanhui Xu; Koji Tamada; Lieping Chen
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 6.  Development of secondary lymphoid organs.

Authors:  Troy D Randall; Damian M Carragher; Javier Rangel-Moreno
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

7.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 8.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection.

Authors:  Christian R Engwerda; Manabu Ato; Simona Stäger; Clare E Alexander; Amanda C Stanley; Paul M Kaye
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 10.  Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Donato Rigante; Giuseppe Lopalco; Antonio Vitale; Orso Maria Lucherini; Caterina De Clemente; Francesco Caso; Giacomo Emmi; Luisa Costa; Elena Silvestri; Laura Andreozzi; Florenzo Iannone; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-06-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.